Technical Analysis for AMGN - Amgen Inc.

Grade Last Price % Change Price Change
grade C 243.59 -1.52% -3.77
AMGN closed down 1.52 percent on Tuesday, August 4, 2020, on 74 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical AMGN trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze Ended Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Bollinger Band Squeeze Range Contraction -1.52%
Lower Bollinger Band Walk Weakness -1.52%
Hammer Candlestick Bullish -0.44%
Lizard Bullish Bullish Day Trade Setup -0.44%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.44%
Bollinger Band Squeeze Range Contraction -0.44%
BB Squeeze + Lower Band Touch Range Contraction -0.44%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. Its principal products include Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body fight infections; Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases; Aranesp and EPOGEN erythropoiesis-stimulating agents that stimulate the production of red blood cells; and XGEVA/Prolia (denosumab) to treat men with castration-resistant prostate cancer at high risk of developing bone metastases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides product candidates in mid- to late-stage development in various therapeutic areas comprising oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine, which includes neuroscience. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc; Takeda Pharmaceutical Company Limited; and UCB, as well as a strategic alliance with Astellas Pharma Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Medicine Biotechnology Drugs Pharmaceutical Products Healthcare Providers Inflammation Neuroscience Dialysis Inflammatory Diseases Wholesale Distributors Cancer Care Amgen Recombinant Proteins Castration Resistant Prostate Cancer Growth Factors Human Therapeutic Products

Is AMGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 264.97
52 Week Low 177.05
Average Volume 2,570,066
200-Day Moving Average 227.56
50-Day Moving Average 239.48
20-Day Moving Average 251.90
10-Day Moving Average 249.67
Average True Range 6.36
ADX 18.97
+DI 23.03
-DI 32.69
Chandelier Exit (Long, 3 ATRs ) 245.90
Chandelier Exit (Short, 3 ATRs ) 258.46
Upper Bollinger Band 261.14
Lower Bollinger Band 242.65
Percent B (%b) 0.05
BandWidth 7.34
MACD Line 1.31
MACD Signal Line 3.40
MACD Histogram -2.091
Fundamentals Value
Market Cap 177.75 Billion
Num Shares 730 Million
EPS 10.98
Price-to-Earnings (P/E) Ratio 22.18
Price-to-Sales 5.59
Price-to-Book 4.07
PEG Ratio 3.29
Dividend 4.60
Dividend Yield 1.89%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 250.84
Resistance 3 (R3) 250.89 248.53 249.63
Resistance 2 (R2) 248.53 246.69 248.50 249.23
Resistance 1 (R1) 246.06 245.55 244.88 246.01 248.82
Pivot Point 243.70 243.70 243.11 243.67 243.70
Support 1 (S1) 241.23 241.85 240.05 241.17 238.36
Support 2 (S2) 238.87 240.71 238.84 237.95
Support 3 (S3) 236.40 238.87 237.55
Support 4 (S4) 236.34